Scientists glimpse a rare human antibody which protects against AIDSAugust 08, 2001Scientists have obtained their first detailed glimpse of a rare antibody, called b12, which is capable of inactivating many different strains of HIV, the virus which causes AIDS. A crystal structure of b12 has been determined by scientists working at The Scripps Research Institute, California, and the Glycobiology Institute at Oxford University, which shows that the antibody has a long finger-like region on its surface that is able to penetrate the surface of the HIV virus and prevent it causing disease. It is hoped that the structure of this region may provide a basis for the design of effective vaccines against the HIV virus. HIV damages the immune system by binding to special receptors, called CD4 receptors, which are found on the surface of specialised blood cells, such as T cells or macrophages, which defend the body against disease. The virus infects the cells via the receptors, and impairs their function so that patients with HIV become vulnerable to many different infections. b12 was first identified in the bone marrow of a 31 year old male who had been HIV positive without symptoms for six years and is believed to work by binding onto the area of the viral coat which interacts with CD4 receptors, neutralising it and making the virus unable to invade cells. Whilst the antibody is rare, its existence demonstrates that the human immune system is capable of raising antibodies that are effective against HIV, and scientists will now be investigating the ways in which this type of immune response can be triggered. The search for a vaccine against HIV has been made particularly complicated by the fact that there are many subtypes of HIV. The b12 antibody appears to be effective against a wide variety of these isolates, as the region of b12 which binds the virus is shaped so that it can bind most of the viral strains and the paper, authored by Erica Ollmann Saphire and co-workers under the direction of Ian A. Wilson and Dennis R. Burton, offers a critical template for the design of HIV vaccines Dr Pauline Rudd, a Reader in Glycobiology at the Department of Biochemistry, Oxford University, and Professor Raymond Dwek, Director of the Glycobiology Institute, said: "We are delighted to be collaborating with The Scripps Research Institute on this important project, which will hopefully offer real solutions to the problems of designing an effective virus against AIDS." Oxford, University of |
|||||||||||||||||||||
| Related AIDS Current Events and AIDS News Articles Many pregnant women avoid HIV screening in Africa 'Prevention is the best cure' is a common expression, but what happens if preventative measures are not used? A large proportion of pregnant Ugandan women are going out of their way not to be HIV tested, increasing the risk of mother-to-child transmission. An atomic-level look at an HIV accomplice Since the discovery in 2007 that a component of human semen called SEVI boosts infectivity of the virus that causes AIDS, researchers have been trying to learn more about SEVI and how it works, in hopes of thwarting its infection-promoting activity. UAB Researchers Discover Antibody Receptor Identity, Propose Renaming Immune-System Gene Researchers at the University of Alabama at Birmingham (UAB) have uncovered the genetic identity of a cellular receptor for the immune system's first-response antibody, a discovery that sheds new light on infection control and immune disorders. UCLA study shows brain's ability to reorganize Visually impaired people appear to be fearless, navigating busy sidewalks and crosswalks, safely finding their way using nothing more than a cane as a guide. Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease. Prioritizing low-cost, simple health measures would save 2.5 million child lives a year Almost a third of the children under age five who die each year could be saved if governments rebalance health spending to ensure low-cost, simple interventions such as safe water and hygiene, bed nets and basic maternal and newborn care, leading aid agency World Vision said today. Currently, 8.8 million children a year die before age five, most of preventable causes. No-entry zones for AIDS virus The AIDS virus inserts its genetic material into the genome of the infected cell. Scientists of the German Cancer Research Center have now shown for the first time that the virus almost entirely spares particular sites in the human genetic material in this process. This finding may be useful for developing new, specific AIDS drugs. Hoping for a fluorescent basket case Although recent advances have raised hopes that a protective vaccine can be developed, acquired immunodeficiency syndrome (AIDS) remains a major public health problem. Athletes on performance enhancers more likely to abuse alcohol, other drugs College athletes who use performance-enhancing substances may be at heightened risk of misusing alcohol and using recreational drugs as well, according to new research in the Journal of Studies on Alcohol and Drugs. Children with autism show slower pupil responses, MU study finds Autism affects 1 in 150 children today, making it more common than childhood cancer, juvenile diabetes and pediatric AIDS combined. More AIDS Current Events and AIDS News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||